Actively Recruiting
Cancer Loyalty Card Study 2 (CLOCS-2)
Led by Imperial College London · Updated on 2026-03-25
2900
Participants Needed
1
Research Sites
60 weeks
Total Duration
On this page
Sponsors
I
Imperial College London
Lead Sponsor
U
University of Birmingham
Collaborating Sponsor
AI-Summary
What this Trial Is About
Cancer is one of the leading causes of mortality worldwide and is responsible for an estimated 9.6 million deaths yearly. Cancer-related deaths can be reduced if patients are diagnosed and treated early. Delay in cancer diagnosis can occur at any point along the diagnostic spectrum, from the first observation of symptoms to the start of treatment. Diagnosing cancer when it is still at an early stage, before it has spread, gives surgery, radiotherapy and other treatments the best chance of working. Therefore, early diagnosis is the most important way to improve cancer outcomes.Most of the cancers usually presents with vague and non-alarming symptoms. Most individuals are diagnosed late when the cancer has already spread, and the prognosis is poor. There are over 200 different types of cancer that can cause many different signs and symptoms. Sometimes symptoms affect specific body areas, such as abdomen or skin. But signs can also be more general, and include weight loss, tiredness (fatigue) or unexplained pain. The type of symptoms varies from person to person. The major reasons for not presenting to the GP with symptoms such as these are "not wanting to waste the GP's time" and normalisation of these symptoms. The persistence of a symptom, social influence and awareness encourage help-seeking behaviours in primary care. However, few believe their symptom(s) might be a sign of cancer. Consequently, people might choose to self-manage their symptoms by using over-the-counter medication, and to seek advice from other sources, (pharmacists, family, internet), rather than a primary care physician. RATIONALE FOR CURRENT STUDY An early cancer diagnosis is essential for receiving treatment as early as possible to have the best chance for successful treatment. Early diagnosis of cancer can be challenging. Sometimes, the cancer symptoms resemble common illnesses and could resolve with the use of over-the-counter medications and other remedies until they become persistent or debilitating. The present study focuses on ten cancer forms: colon, oesophageal, stomach, liver, bladder, uterine, vulval, ovarian, endometrial and pancreatic. Patients diagnosed with the cancers mentioned above often report experiencing vague symptoms (such as abdominal or back pain, indigestion, feeling full etc). They often use over-the-counter medication to manage their symptoms before seeing a doctor. Information about how often and what products participants purchase (e.g. pain killers, digestive products and natural remedies) to care for these symptoms could help identify these cancers a few crucial weeks or months earlier and encourage people to seek help sooner from their doctors.
CONDITIONS
Official Title
Cancer Loyalty Card Study 2 (CLOCS-2)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals aged over 18 years
- Individuals must reside in the United Kingdom when giving informed consent
- Individuals must be registered with an NHS GP Practice
- For cases: diagnosed with bladder, colorectal, endometrial, liver, oesophageal, ovarian, pancreatic, stomach, uterine, or vulvar cancer in the last 24 months
- For controls: no cancer diagnosis of any type in the last 6 years except non-melanoma skin cancer
- Must be the primary registered cardholder of a Tesco Clubcard or Boots Advantage Card loyalty card and consent to share data
- Provision of written informed consent
- Willing and able to comply with all study activities
- If not the primary cardholder, the primary cardholder from the same household must also enroll
You will not qualify if you...
- Individuals under 18 years old
- Non-UK residents at time of giving informed consent
- Individuals without an eligible loyalty card and no one in their household with one
- Individuals who are not the primary registered cardholder and where the primary cardholder is unwilling to join or does not make purchases for them
- For cases: diagnosed with eligible cancer more than 24 months ago (except non-melanoma skin cancer)
- For cases: received an ineligible cancer diagnosis within the last 6 years (except non-melanoma skin cancer)
- For controls: received any cancer diagnosis in the last 6 years except non-melanoma skin cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Imperial College Healthcare NHS Trust
London, United Kingdom
Actively Recruiting
Research Team
Y
Yuscah Pondeca
CONTACT
D
Dr James Flanagan
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here